Maman A, Sussman K E
Compr Ther. 1978 Jun;4(6):40-8.
A case can be made that life expectancy has been prolonged in the diabetic, and some disabling symptoms have been ameliorated by the more recent procedures employed in the management of coronary artery disease and nephropathy. At the same time, the procedures described admittedly present problems and may not be generally available to the vast majority of diabetics. The definitive answer lies in attempting to control diabetes to prevent the development of these and other complications. A number of laboratories are attempting to develop an artificial pancreas or islet transplantation to substitute for the insulin secretory capacity that has been lost or impaired. This is an area of research that demands the highest priority. One cannot be confident that present therapeutic programs can be altered to provide the type of diabetic control necessary for the prevention of complications.
可以证明，糖尿病患者的预期寿命已经延长，并且通过最近用于治疗冠状动脉疾病和肾病的方法，一些致残症状已经得到改善。与此同时，所描述的这些方法诚然存在问题，而且绝大多数糖尿病患者可能无法普遍采用。最终的答案在于努力控制糖尿病，以预防这些及其他并发症的发生。许多实验室正在尝试研发人工胰腺或胰岛移植技术，以替代已经丧失或受损的胰岛素分泌能力。这是一个急需高度优先研究的领域。人们无法确定目前的治疗方案能否改变，以提供预防并发症所需的糖尿病控制类型。
